Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)
Japan · Delayed Price · Currency is JPY 1,022.00
-9.00 (-0.87%)
Aug 6, 2026, 1:46 PM JST
TYO:6039 Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,592 | 1,107 | 1,337 | 1,916 | 1,068 |
Cash & Short-Term Investments | 1,592 | 1,107 | 1,337 | 1,916 | 1,068 |
Cash Growth | 43.81% | -17.20% | -30.22% | 79.40% | -12.03% |
Receivables | 359 | 320 | 290 | 254 | 221 |
Inventory | 93 | 94 | 97 | 126 | 128 |
Other Current Assets | 66 | 76 | 53 | 100 | 122 |
Total Current Assets | 2,110 | 1,597 | 1,777 | 2,396 | 1,539 |
Property, Plant & Equipment | 8,218 | 6,316 | 6,151 | 5,333 | 4,707 |
Long-Term Investments | 294 | 253 | 239 | 191 | 158 |
Goodwill | 122 | 142 | 162 | 183 | 489 |
Other Intangible Assets | 433 | 337 | 386 | 425 | 27 |
Long-Term Deferred Tax Assets | 134 | 106 | 53 | 49 | 45 |
Other Long-Term Assets | 2 | 2 | 2 | 1 | 1 |
Total Assets | 11,313 | 8,753 | 8,770 | 8,578 | 6,966 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 72 | 65 | 58 | 83 | 65 |
Accrued Expenses | 178 | 182 | 118 | 87 | 79 |
Short-Term Debt | 2,038 | - | - | - | - |
Current Portion of Long-Term Debt | 644 | 627 | 626 | 582 | 546 |
Current Income Taxes Payable | 563 | 422 | 558 | 149 | 88 |
Other Current Liabilities | 242 | 258 | 178 | 368 | 187 |
Total Current Liabilities | 3,737 | 1,554 | 1,538 | 1,269 | 965 |
Long-Term Debt | 2,476 | 2,847 | 3,230 | 3,393 | 3,375 |
Pension & Post-Retirement Benefits | 51 | 46 | 38 | 34 | 27 |
Long-Term Deferred Tax Liabilities | 57 | 76 | 99 | 118 | 25 |
Other Long-Term Liabilities | 111 | 82 | 54 | 58 | 65 |
Total Liabilities | 6,432 | 4,605 | 4,959 | 4,872 | 4,457 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 801 | 801 | 796 | 791 | 385 |
Additional Paid-In Capital | 720 | 720 | 712 | 711 | 315 |
Retained Earnings | 3,912 | 3,179 | 2,712 | 2,375 | 1,994 |
Treasury Stock | -553 | -553 | -410 | -171 | -186 |
Comprehensive Income & Other | 1 | 1 | 1 | - | 1 |
Shareholders' Equity | 4,881 | 4,148 | 3,811 | 3,706 | 2,509 |
Total Liabilities & Equity | 11,313 | 8,753 | 8,770 | 8,578 | 6,966 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 5,158 | 3,474 | 3,856 | 3,975 | 3,921 |
Net Cash (Debt) | -3,566 | -2,367 | -2,519 | -2,059 | -2,853 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -275.92 | -182.52 | -181.18 | -165.74 | -234.66 |
Filing Date Shares Outstanding | 12.92 | 12.92 | 13.17 | 13.69 | 11.63 |
Total Common Shares Outstanding | 12.92 | 12.92 | 13.17 | 13.68 | 11.63 |
Working Capital | -1,627 | 43 | 239 | 1,127 | 574 |
Book Value Per Share | 377.66 | 320.96 | 289.27 | 271.00 | 215.68 |
Tangible Book Value | 4,326 | 3,669 | 3,263 | 3,098 | 1,993 |
Tangible Book Value Per Share | 334.71 | 283.90 | 247.68 | 226.54 | 171.32 |